$2.4 billion by 2028: Image-Guided Radiation Therapy Market Forecast, Factors and Growth Trajectory

The Image-Guided Radiation Therapy Market is on an upward trajectory, driven by a confluence of factors that include robust healthcare infrastructure, the growing prevalence of cancer, favorable reimbursement policies, technological innovations, active research initiatives, well-defined regulatory frameworks, increasing adoption of minimally invasive procedures, and the presence of key market players in developing regions. In this blog post, we will delve deeper into these dynamics, trends, and challenges.

A Promising Growth Trajectory

The Image-Guided Radiation Therapy Market is poised for substantial growth, with projections indicating that it will reach an impressive USD 2.4 billion by 2028, compared to USD 1.9 billion in 2023. This growth is expected to be at a steady CAGR of 5.2% during the forecast period.

Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171554723

Driving Forces Several factors are propelling the expansion of the Image-Guided Radiation Therapy Market:

  1. Aging Population: The global increase in the aging population has led to a higher prevalence of cancer, driving the demand for advanced cancer treatment options.
  2. Rising Cancer Cases: The growing incidence of cancer worldwide necessitates more precise and effective treatment options.
  3. Technological Advancements: Ongoing technological innovations in radiation therapy devices are enhancing their precision and effectiveness.
  4. Government Initiatives: Governments across the globe are actively involved in cancer control programs, supporting the adoption of advanced treatment modalities like IGRT.
  5. Patient Comfort: IGRT’s precision reduces the need for frequent patient repositioning during treatment, enhancing patient comfort, particularly for those undergoing breast cancer treatment.

Challenges and Opportunities In the dynamic landscape of IGRT, there are challenges and opportunities:


  1. Competition: IGRT faces competition from automated radiation therapy systems, Intensity Modulated Radiation Therapy (IMRT), and other radiotherapeutic approaches.


  1. Emerging Markets: Untapped regions present substantial growth opportunities as awareness and access to advanced cancer treatments improve.
  2. Advanced Devices: The adoption of advanced IGRT devices, such as PET/MRI-guided radiation therapy, is expected to grow, offering more precise treatment options.

Market Segmentation

The IGRT market is segmented based on products, procedures, applications, and end-users:

  • Products: LINAC (linear accelerator), 4D gating/4D RT, PET/MRI-guided radiation therapy, CT scanning, and portal imaging.
  • Procedures: 3D conformal therapy, stereotactic therapy, proton beam therapy, intensity modulation radiation therapy, and particle therapy.
  • Applications: Breast cancer, prostate cancer, head & neck cancer, lung cancer, gastrointestinal cancer, gynecological cancer, and others.
  • End-users: Hospitals and independent radiotherapy centers.

Hospitals: The Hub of Cancer Care

Hospitals are expected to dominate the IGRT market. Their comprehensive healthcare provisions, advanced infrastructure, collaborative environments, and dedication to patient-centered care make them ideal for IGRT adoption. Hospitals efficiently manage the influx of cancer patients, aligning perfectly with IGRT’s goal of providing precise and comfortable treatment.

Regional Dominance

North America is poised to lead the IGRT market, driven by its advanced healthcare infrastructure, high cancer incidence, and robust reimbursement frameworks. The region fosters the assimilation of progressive treatments, including IGRT, making it a pivotal hub for IGRT research, manufacturing, and adoption.

Request for Sample Pages: – https://www.marketsandmarkets.com/requestsampleNew.asp?id=171554723

Innovations Shaping the Future

Key players like Siemens Healthineers, Elekta, and Accuray Incorporated are at the forefront of IGRT innovations.

Recent developments

Recent developments, such as Philips’ Zenition 10, GE HealthCare’s advances in PET/MR capabilities, and the launch of Pixxoscan, highlight the industry’s commitment to advancing cancer care.


Image-Guided Radiation Therapy is revolutionizing cancer treatment by offering precise, patient-centric care. As a medical industry expert, I’m thrilled to witness this transformation. With continued advancements, a supportive healthcare ecosystem, and a global focus on non-invasive cancer interventions, IGRT is set to play a pivotal role in shaping the future of cancer treatment worldwide. As the industry embraces innovation, research, and collaboration, the promise of improved cancer outcomes becomes increasingly achievable.